# Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

> **NCT02270255** · PHASE2 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 44 (actual)

## Conditions studied

- Leiomyoma

## Interventions

- **PROCEDURE:** Superior hypogastric nerve block
- **DRUG:** 0.75% Ropivacaine
- **PROCEDURE:** Subcutaneous injection
- **DRUG:** 1% Xylocaine

## Key facts

- **NCT ID:** NCT02270255
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02270255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02270255, "Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02270255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*